Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
23 results
D1.437 - A Decade of Research on Janus Kinase Inhibitors in Atopic Dermatitis: A Global Bibliometric Analysis (2015–2024)
D1.438 - Dupilumab for Moderate-to-Severe Atopic Dermatitis in Children and Adolescents: Real-Life Assessment of Efficacy and Safety
D1.442 - Design and Preclinical Development of a Bispecific Antibody Targeting IL11 and TL1A
D1.443 - Preclinical Development of a Dual LIGHT/TL1A Bispecific Antibody
D1.447 - Comparison of Disease Duration, Remission, and Other Disease-Related Parameters with the Duration of Omalizumab Treatment in Patients with Chronic Spontaneous Urticaria
D1.448 - Long-Term Efficacy and Stability of Lebrikizumab in Treating Face/Head and Neck Involvement in Patients with Moderate-to-Severe Atopic Dermatitis
D1.449 - A Phase 2, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Briquilimab in Adults with Chronic Urticaria (Trial in Progress)
D1.439 - Urticaria Voices: Physician-reported perspectives of chronic urticaria care and its treatment in China (UV in China)
D2.521 - Reshaping Allergy Assessment Pathways In The United Kingdom: Modeling System-Level Gains Through Discrete Event Simulation
D2.522 - An Observational Study of techniques of Intanasal Spray in Allergic Rhinitis
D2.532 - Does Bathing Frequency Matter in Pediatric Atopic Dermatitis? Insights from Real-Life Practice
D2.533 - Characterizing Elderly Asthma Hospitalizations: Insights into Treatment Gaps and Outcomes; A Real‑World Study Using the MIMIC‑IV Dataset
D2.523 - Dyadic parenting stress and marital communication among parents of young children with food allergies
D2.528 - Corticophobia Among Caregivers of Children with Atopic Diseases: Causes and Outcomes
D2.529 - Asymptomatıc QT Prolongatıon Developıng After Antıhıstamıne Use
D2.531 - Expert Panel Discussion on a New Oral On-Demand Treatment in Hereditary Angioedema
D2.536 - Seasonal Influenza Vaccination: Uptake Rate, Profile, and Motivating Factors Among Healthcare Workers
D2.537 - Advances in Drug Allergy & Penicillin Testing Phase 2 (ADAPT-2): an AI-powered drug allergy educational initiative spanning across 4 localities
D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region
D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download